Stimulation of β-amyloid precursor protein α-processing by phorbol ester involves calcium and calpain activation

Biochemical and Biophysical Research Communications

Volumn 316, Issue 2, 2004, Pages 332-340

  Chen, Ming ^a,b   Fernandez, Hugo L ^a,b  

^a Bay Pines VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Aging; Alzheimer; Amyloid; Calcium; Calpain

Indexed keywords

AMYLOID BETA PROTEIN; BETA AMYLOID PRECURSOR PROTEIN ALPHA; CALCIUM; CALCIUM 21; CALPAIN; CALPASTATIN; EGTAZIC ACID; FIBRONECTIN; MICROTUBULE ASSOCIATED PROTEIN 2; PHORBOL DIBUTYRATE; PHORBOL ESTER; PROTEINASE INHIBITOR; TAU PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; FIBROBLAST; HUMAN; HUMAN CELL; HYDROLYSIS; MEASUREMENT; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SECRETION; SENSITIVITY ANALYSIS; STIMULATION;

AMYLOID BETA-PROTEIN PRECURSOR; CALCIUM; CALPAIN; CELLS, CULTURED; CHELATING AGENTS; EGTAZIC ACID; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBRONECTINS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PEPTIDE FRAGMENTS; PHORBOL 12,13-DIBUTYRATE; TAU PROTEINS;

EID: 1542512477     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.052     Document Type: Article

References (61)

1. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
2. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
3. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
4. Buxbaum J.D., Ruefli A.A., Parker C.A., Cypess A.M., Greengard P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. USA. 91:1994;4489-4493.
5. Jacobsen J.S., Spruyt M.A., Brown A.M., Sahasrabudhe S.R., Blume A.J., Vitek M.P., Muenkel H.A., Sonnenberg-Reines J. The release of Alzheimer's disease beta amyloid peptide is reduced by phorbol treatment. J. Biol. Chem. 269:1994;8376-8382.
6. Hung A.Y., Selkoe D.J. Selective ectodomain phosphorylation and regulated cleavage of beta-amyloid precursor protein. EMBO J. 13:1994;534-542.
7. Savage M.J., Trusko S.P., Howland D.S., Pinsker L.R., Mistretta S., Reaume A.G., Greenberg B.D., Siman R., Scott R.W. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18:1998;1743-1752.
8. Buxbaum J.D., Liu K.N., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273:1998;27765-27767.
9. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R.et al. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA. 96:1999;3922-3927.
10. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA. 89:1992;10075-10078.
11. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., Greengard P. Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 89:1992;3055-3059.
12. Loffler J., Huber G. Modulation of beta-amyloid precursor protein secretion in differentiated and nondifferentiated cells. Biochem. Biophys. Res. Commun. 195:1993;97-103.
13. Nitsch R.M., Farber S.A., Growdon J.H., Wurtman R.J. Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA. 90:1993;5191-5193.
14. Lee R.K., Wurtman R.J., Cox A.J., Nitsch R.M. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA. 92:1995;8083-8087.
15. Kim S.-H., Kim Y.-K., Jeong S.-J., Haass C., Kim Y.-H., Sun Y.-H. Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine. Mol. Pharmacol. 52:1997;430-436.
16. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J.et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4:1998;447-451.
17. da Cruz e Silva O.A., Iverfeldt K., Oltersdorf T., Sinha S., Lieberburg I., Ramabhadran T.V., Suzuki T., Sisodia S.S., Gandy S., Greengard P. Regulated cleavage of Alzheimer beta-amyloid precursor protein in the absence of the cytoplasmic tail. Neuroscience. 57:1993;873-877.
18. Pontremoli S., Melloni E., Michetti M., Sparatore B., Salamino F., Sacco O., Horecker B.L. Phosphorylation and proteolytic modification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13-acetate. Proc. Natl. Acad. Sci. USA. 84:1987;3604-3608.
19. Kishimoto A., Mikawa K., Hashimoto K., Yasuda I., Tanaka S., Tominaga M., Kuroda T., Nishizuka Y. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J. Biol. Chem. 264:1989;4088-4092.
20. Bronk S.F., Gores G.J. pH-dependent nonlysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes. Am. J. Physiol. 264:1993;G744-G751.
21. Guttmann R.P., Johnson G.V. Oxidative stress inhibits calpain activity in situ. J. Biol. Chem. 273:1998;13331-13338.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
24. Chen M., Durr J., Fernandez H.L. Possible role of calpain in normal processing of Alzheimer's beta-amyloid precursor protein. Biochem. Biophys. Res. Commun. 273:2000;170-175.
25. Li Q.X., Evin G., Small D.H., Multhaup G., Beyreuther K., Masters C.L. Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets. J. Biol. Chem. 270:1995;14140-14147.
26. Skovronsky D.M., Lee V.M.-Y., Pratico D. Amyloid precursor protein and amyloid beta peptide in human platelets. J. Biol. Chem. 276:2001;17036-17043.
27. Jolly-Tornetta C., Gao Z.-Y., Lee V.M.-Y., Wolf B.A. Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons (NT2N). J. Biol. Chem. 273:1998;14015-14021.
28. Racchi M., Solano D.C., Sironi M., Govoni S. Activity of alpha-secretase as the common final effector of protein kinase C-dependent and -independent modulation of amyloid precursor protein metabolism. J. Neurochem. 72:1999;2464-2470.
29. Wolf G., Zerlauth G. Tumor promotion, vitamin A, and fibronectin. A review of recent work. Prog. Clin. Biol. Res. 259:1988;201-216.
30. Scheidl H., Scita G., Sampson P.H., Park H.Y., Wolf G. The effect of sphingosine and phorbol ester on the signal transduction enzymes and fibronectin release in cell culture. Biochim. Biophys. Acta. 1135:1992;295-300.
31. Lee G., Rook S.L. Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J. Cell Sci. 102(Pt. 2):1992;227-237.
32. Johnson G.V., Litersky J.M., Jope R.S. Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56:1991;1630-1638.
33. Hong D.H., Huan J., Ou B.R., Yeh J.Y., Saido T.C., Cheeke P.R., Forsberg N.E. Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain. Biochim. Biophys. Acta. 1267:1995;45-54.
34. Wang K.K. Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11:1990;139-142.
35. Walsh D.M., Williams C.H., Kennedy H.E., Allsop D. An investigation into the proteolytic cleavage of Alzheimer amyloid precursor protein in PC-12 cells. Biochem. Soc. Trans. 22:1994;14S.
36. Yamazaki T., Haass C., Saido T.C., Omura S., Ihara Y. Specific increase in amyloid beta-protein 42 secretion ratio by calpain inhibition. Biochemistry. 36:1997;8377-8383.
37. Saido T.C., Sorimachi H., Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 811:1994;814-822.
38. De Lisle R.C., Williams J.A. Regulation of membrane fusion in secretory exocytosis. Annu. Rev. Physiol. 48:1986;225-238.
39. Suzuki T., Nairn A.C., Gandy S.E., Greengard P. Phosphorylation of Alzheimer amyloid precursor protein by protein kinase, C. Neuroscience. 48:1992;755-761.
40. Shin J.E., Koh J.Y., Mook-Jung I. Presenilin 1 mediates protein kinase C dependent alpha-secretase derived amyloid precursor protein secretion and mitogen-activated protein kinase activation in presenilin 1 transfected human embryonic kidney 293 cell. Neurosci. Lett. 269:1999;99-102.
41. Desdouits-Magnen J., Desdouits F., Takeda S., Syu L.J., Saltiel A.R., Buxbaum J.D., Czernik A.J., Nairn A.C., Greengard P. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J. Neurochem. 70:1998;524-530.
42. Marambaud P., Chevallier N., Barelli H., Wilk S., Checler F. Proteasome contributes to the alpha-secretase pathway of amyloid precursor protein in human cells. J. Neurochem. 68:1997;698-703.
43. Parvathy S., Hussain I., Karran E.H., Turner A.J., Hooper N.M. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry. 37:1998;1680-1685.
44. Xu H., Greengard P., Gandy S. Regulated formation of Golgi secretory vesicles containing Alzheimer beta-amyloid precursor protein. J. Biol. Chem. 270:1995;23243-23245.
45. Skovronsky D.M., Moore D.B., Milla M.E., Doms R.W., Lee V.M. Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-Golgi network. J. Biol. Chem. 275:2000;2568-2575.
46. Mills J., Reiner P.B. Regulation of amyloid precursor protein cleavage. J. Neurochem. 72:1999;443-460.
47. Chen M. Alzheimer's α-secretase may be a calcium-dependent protease. FEBS Lett. 417:1997;163-167.
48. Wolf B.A., Wertkin A.M., Jolly Y.C., Yasuda R.P., Wolfe B.B., Konrad R.J., Manning D., Ravi S., Williamson J.R., Lee V.M.-Y. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells. J. Biol. Chem. 270:1995;4916-4922.
49. Chen M., Fernandez H.L. Where do Alzheimer's plaques and tangles come from? Aging-induced protein degradation inefficiency. Front. Biosci. 6:2001;e1-e11.
50. Garcia-Sierra F., Ghoshal N., Quinn B., Berry R.W., Binder L.I. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J. Alzheimers Dis. 5:2003;65-77.
51. Yang L.S., Ksiezak-Reding H. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233:1995;9-17.
52. Trojanowski J.Q., Lee V.M.-Y. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J. 9:1995;1570-1576.
53. Masliah E., Iimoto D.S., Saitoh T., Hansen L.A., Terry R.D. Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss? Brain Res. 531:1990;36-44.
54. David L.L., Shearer T.R., Shih M. Sequence analysis of lens beta-crystallins suggests involvement of calpain in cataract formation. J. Biol. Chem. 268(3):1993;1937-1940.
55. Mathews P.M., Jiang Y., Schmidt S.D., Grbovic O.M., Mercken M., Nixon R.A. Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments. J. Biol. Chem. 277:2002;36415-36424.
56. Zhang L., Song L., Parker E.M. Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production. J. Biol. Chem. 274:1999;8966-8972.
57. 2+ so difficult to measure? Cell Calcium. 26:1999;149-154.
58. Squier T.C., Bigelow D.J. Protein oxidation and age-dependent alterations in calcium homeostasis. Front. Biosci. 5:2000;D504-D526.
59. Frautschy S.A., Horn D.L., Sigel J.J., Harris-White M.E., Mendoza J.J., Yang F., Saido T.C., Cole G.M. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J. Neurosci. 1998;188311-188321.
60. Hajimohammadreza I., Anderson V.E., Cavanagh J.B., Seville M.P., Nolan C.C., Anderton B.H., Leigh P.N. beta-Amyloid precursor protein fragments and lysosomal dense bodies are found in rat brain neurons after ventricular infusion of leupeptin. Brain Res. 640:1994;25-32.
61. Ivy G.O., Kitani K., Ihara Y. Anomalous accumulation of tau and ubiquitin immunoreactivities in rat brain caused by protease inhibition and by normal aging: a clue to PHF pathogenesis? Brain Res. 498:1989;360-365.